Thrive Capital Management, LLC

Institutional investor · Portfolio as of Q4 2025

Top Holdings4 positions

Checking export access…
Activity:
FIG

Figma, Inc.

4.4M$164.3M46.7%$51.87-27.95%
2 qtrssince 2025-Q3
Increased
Unranked
CVNA

Carvana Co.

226,761$95.7M27.2%$8.10+942.65%
16 qtrssince 2022-Q1
Unchanged
0
OSCR

Oscar Health, Inc.

6.3M$91.2M25.9%$16.40-12.38%
18 qtrssince 2021-Q3
Unchanged
0
STUB

StubHub Holdings, Inc.

68,745$930,1200.3%$16.84-19.66%
2 qtrssince 2025-Q3
Unchanged
0
$352.1M
AUM
4
Positions
Q4 2025
Filing
HI rating · 2.0/5
Quarterly 13F Value Change
Reported 13F value ($M)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2022-Q1$740,576,000-8.07743293631%
2022-Q2$342,270,000-53.7832713996%
2022-Q3$293,647,000-14.2060361703%
2022-Q4$220,535,810-24.8976458128%
2023-Q3$390,494,67477.0663340344%
2025-Q3$480,183,29322.9679493657%
Activity profile
$ moved · Q4'25
New0%Increased58%Decreased0%Exited42%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.1 years
<1Q0%1-4Q50%1-2Y0%2Y+50%

Thrive Capital Management, LLC manages $352.1M across 4 positions as of Q4 2025. Top holdings: FIG (46.7%), CVNA (27.2%), OSCR (25.9%). Fund DNA: High Conviction Activist. HoldingsIntel Score: 2/5.0.

Q4 2025 Summary

Exited VMEO and NU; increased 1, led by FIG (+380 shares). No standout high-conviction moves this quarter. Portfolio: $352M across 4 positions.

Top holdings by portfolio weight

Total AUM$352M
FIG46.67%
CVNA27.18%
OSCR25.89%
STUB0.26%
VMEO0.00%
NU0.00%

Portfolio allocation by GICS sector

Sectors4
Technology46.67%
Consumer Cyclical27.18%
Healthcare25.89%
Communication Services0.26%

Behavioral investing profile

Checking access…
High Conviction Activist- primarily Technology, Consumer Cyclical, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L53
Conviction67
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used